misonidazole has been researched along with Carcinoma, Non-Small Cell Lung in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 13 (52.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourigault, P; Higgins, GS; Macpherson, RE; McGowan, DR; Skwarski, M | 1 |
| Fenwick, JD; Gleeson, FV; Hackett, SL; Higgins, GS; Liu, D; Macpherson, RE; McGowan, DR; McKenna, WG | 1 |
| Huang, Y; Li, L; Liu, W; Lu, H; Wei, Y; Yu, J; Yu, Q; Yuan, S; Zhao, S; Zheng, J | 1 |
| Dong, M; Guo, S; Han, X; Li, G; Li, H; Lin, Y; Mi, Y; Ruan, Q; Wang, B; Xu, D; Zhang, X | 1 |
| Bradley, KM; Campo, L; Fenwick, JD; Gleeson, FV; Green, M; Higgins, GS; Horne, A; Macpherson, RE; Maughan, TS; McCole, MG; McGowan, DR; McKenna, WG; Mohammed, S; Muschel, RJ; Ng, SM; Panakis, N; Prevo, R; Skwarski, M; Strauss, VY; Stuart, R; Tacconi, EMC; Vallis, KA | 1 |
| Aide, N; Berriolo-Riedinger, A; Blagosklonov, O; Brenot-Rossi, I; Bridji, B; Cachin, F; Caignon, JM; Chaumet-Riffaud, P; Collombier, L; Courbon, F; Devillers, A; Doyeux, K; Dubray, B; Fernandez, P; Gremillet, E; Houzard, C; Kolesnikov-Gauthier, H; Modzelewski, R; Olivier, P; Roux, J; Tessonnier, L; Thureau, S; Vera, P; Vervueren, L | 1 |
| Carson, RE; Chan, C; Fung, EK; Jin, X; Liu, C; Mulnix, T; Naganawa, M | 1 |
| Arvold, ND; Heidari, P; Kunawudhi, A; Mahmood, U; Sequist, LV | 1 |
| Akula, MR; Bois, F; Carlson, DJ; Collier, L; Hammond, K; Huang, Y; Kabalka, GW; Kelada, OJ; Ropchan, J; Zheng, MQ | 1 |
| Bradley, KM; Fenwick, JD; Gleeson, FV; Higgins, GS; Macpherson, RE; McGowan, DR | 1 |
| Cui, YL; Li, XF; Wang, X | 1 |
| Bohn, P; Dubray, B; Edet-Sanson, A; Gardin, I; Hapdey, S; Ménard, JF; Modzelewski, R; Salles, A; Thiberville, L; Vera, P | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Askoxylakis, V; Bischof, M; Debus, J; Dimitrakopoulou-Strauss, A; Dinkel, J; Eichinger, M; Haberkorn, U; Huber, PE; Kopp-Schneider, A; Sommer, G; Stieltjes, B; Strauss, LG; Thieke, C | 1 |
| Bares, R; Dittmann, H; Eschmann, SM; Machulla, HJ; Paulsen, F; Reimold, M; Reischl, G; Welz, S | 1 |
| Asadpour, B; Buell, U; Coenen, HH; Demirel, C; Eble, MJ; Gagel, B; Hamacher, K; Kaiser, HJ; Pinkawa, M; Piroth, M; Reinartz, P; Stanzel, S; Zimny, M | 1 |
| Cherk, MH; Foo, SS; Knight, SR; Murone, C; O'Keefe, GJ; Papenfuss, AT; Poon, AM; Sachinidis, JI; Saunder, TH; Scott, AM | 1 |
| Lee, ST; Scott, AM | 1 |
| Bergman, KS; Evans, ML; Graham, MM; Grierson, JR; Koh, WJ; Krohn, KA; Lewellen, TK; Lindsley, KL; Peterson, LM; Rasey, JS | 1 |
| Evans, ML; Graham, MM; Koh, WJ; Krohn, KA; Lewellen, TK; Peterson, LM; Rasey, JS | 1 |
| Bonomi, P; Faber, LP; Reddy, S | 1 |
| Bauer, M; Byhardt, RW; Doggett, RL; Emami, B; Mowry, PA; Perez, CA; Phillips, TL; Simpson, JR; Wasserman, TH | 1 |
| Artim, RA; Carlson, RW; Coleman, CN; Gribble, M; Halsey, J; Kohler, M; Lawrence, HJ; Sampson, WI; Sikic, BI; Wong, P | 1 |
| Jakobsson, M; Kylmämaa, T; Taskinen, PJ | 1 |
| Bauer, M; Durbin, LM; Emami, B; Perez, CA; Simpson, JR; Wasserman, TH; Wiegensberg, I; Zinninger, M | 1 |
2 review(s) available for misonidazole and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole.
Topics: Animals; Brain Ischemia; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorine Radioisotopes; Glioma; Head and Neck Neoplasms; Humans; Lung Neoplasms; Misonidazole; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stroke | 2007 |
Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Lung Neoplasms; Misonidazole; Neoplasm Metastasis; Prognosis; Radiotherapy; Radiotherapy Dosage; Survival Rate | 1990 |
10 trial(s) available for misonidazole and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.
Topics: Adenocarcinoma of Lung; Aged; Aminopyridines; Anorexia; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Fatigue; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Misonidazole; Morpholines; Nausea; Phosphoinositide-3 Kinase Inhibitors; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents; Radiotherapy; Tumor Hypoxia | 2019 |
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer.
Topics: Adult; Aged; Algorithms; Carcinoma, Non-Small-Cell Lung; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Misonidazole; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tumor Burden | 2013 |
Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.
Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Humans; Hypoxia; Lung Neoplasms; Magnetic Resonance Imaging; Misonidazole; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Fluorine Radioisotopes; Germany; Head and Neck Neoplasms; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Misonidazole; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2005 |
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Deoxycytidine; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gemcitabine; Glucose; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Misonidazole; Positron-Emission Tomography; Prospective Studies; Pulmonary Embolism; Radiopharmaceuticals; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
Concurrent chemotherapy and thoracic irradiation in non-small cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Evaluation; Fluorouracil; Humans; Lung Neoplasms; Misonidazole; Neoplasm Metastasis; Prognosis; Radiotherapy; Radiotherapy Dosage; Survival Rate | 1990 |
Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Lung Neoplasms; Middle Aged; Misonidazole; Multicenter Studies as Topic; Prognosis; Prospective Studies; Random Allocation | 1989 |
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melphalan; Middle Aged; Misonidazole | 1988 |
Misonidazole combined with radiotherapy in the treatment of non-small cell lung cancer. A randomized double-blind trial.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Prognosis; Radiation-Sensitizing Agents; Random Allocation | 1987 |
Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
Topics: Adolescent; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Prognosis; Radiation-Sensitizing Agents; Random Allocation | 1987 |
14 other study(ies) available for misonidazole and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients.
Topics: Atovaquone; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Humans; Hypoxia; Lung Neoplasms; Misonidazole; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Topics: Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Humans; Kinetics; Lung Neoplasms; Misonidazole; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2017 |
To Explore a Representative Hypoxic Parameter to Predict the Treatment Response and Prognosis Obtained by [
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Female; Humans; Hypoxia; Kaplan-Meier Estimate; Logistic Models; Lung Neoplasms; Male; Middle Aged; Misonidazole; Progression-Free Survival; Proportional Hazards Models; Treatment Outcome | 2018 |
Dosimetry study of
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Humans; Hypoxia; Lung Neoplasms; Male; Middle Aged; Misonidazole; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated | 2018 |
Event-by-event respiratory motion correction for PET with 3D internal-1D external motion correlation.
Topics: Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Healthy Volunteers; Humans; Hypoxia; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Insulin-Secreting Cells; Kidney; Lung Neoplasms; Misonidazole; Movement; Pancreas; Positron-Emission Tomography; Regression Analysis; Reproducibility of Results; Respiration; Signal Processing, Computer-Assisted; Tetrabenazine; X-Ray Microtomography | 2013 |
Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Mice, Nude; Misonidazole; Molecular Targeted Therapy; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2016 |
Synthesis of [(18)F]FMISO in a flow-through microfluidic reactor: Development and clinical application.
Topics: Adenocarcinoma; Aged; Carcinoma, Non-Small-Cell Lung; Fluorine Radioisotopes; Humans; Hypoxia; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Microfluidics; Misonidazole; Pilot Projects; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiochemistry; Tissue Distribution | 2015 |
18F-Misonidazole PET-CT scan detection of occult bone metastasis.
Topics: Aged; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Diagnosis, Differential; Humans; Lung Neoplasms; Male; Misonidazole; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
(18)F-fluoromisonidazole PET reveals spatial and temporal heterogeneity of hypoxia in mouse models of human non-small-cell lung cancer.
Topics: Animals; Autoradiography; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; Heterografts; Humans; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Mice; Mice, Nude; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients wit
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Misonidazole; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Statistics as Topic | 2006 |
Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Female; Humans; Lung Neoplasms; Male; Middle Aged; Misonidazole; Oxygen Consumption; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 1995 |
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Fluorine Radioisotopes; Humans; Lung Neoplasms; Male; Misonidazole; Neoplasms; Prostatic Neoplasms; Tomography, Emission-Computed | 1996 |